Calliditas Therapeutics AB Aktiespararna

Fall: 65180 SEK i 1 veckor: Frick: Forskningsbolag nära

Stock analysis for Calliditas Therapeutics AB (CALT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2021-04-21 2021-04-21 On average, they expect Calliditas Therapeutics AB (publ)'s stock price to reach $40.80 in the next twelve months. This suggests a possible upside of 51.2% from the stock's current price. View analysts' price targets for Calliditas Therapeutics AB (publ) or view top-rated stocks among Wall Street analysts .

3 hours ago Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden. It focuses on identifying, developing, and commercializing … 2019-01-01 Calliditas Therapeutics AB (publ) currently has 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CALT will outperform the market and that investors should add to their positions of Calliditas Therapeutics AB (publ). View the latest ratings for CALT. 1 day ago Historical daily share price chart and data for Calliditas Therapeutics AB since 2021 adjusted for splits. The latest closing stock price for Calliditas Therapeutics AB as of March 31, 2021 is 27.57..

1 månader: Inkomst 17182 SEK: Calliditas therapeutics aktie

View real-time stock prices and stock quotes for a full financial overview. Stock analysis for Calliditas Therapeutics AB (CALT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2021-04-21 2021-04-21 On average, they expect Calliditas Therapeutics AB (publ)'s stock price to reach $40.80 in the next twelve months. This suggests a possible upside of 51.2% from the stock's current price.

CALT Calliditas Therapeutics AB publ Stock Quote - Ee2664c82b

Get the latest Calliditas Therapeutics AB (CALTX) real-time quote, historical performance, charts, and other financial information to help you make more informed Få detaljerad information om Calliditas Therapeutics (CALTX) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Calliditas Therapeutics rapporter Kjøp Calliditas Therapeutics AB (CALTX) aksjen. Calliditas Therapeutics: FDA grants priority review for Nefecon, for patients with IgA Gå til Shareville. Senaste nyheterna om aktien Calliditas Therapeutics (CALTX). De senaste artiklarna från BioStock » Calliditas vinner SwedenBIO Award 2020 » Enzymaticas Calliditas Therapeutics Inc. The following documents filed by Calliditas Therapeutics AB (the “Registrant”) with the U.S. Securities and Exchange Commission ✖ Safari-användare: Om du upplever problem med Shareville, öppna webbläsarens Inställningar -> Integritet, och avbocka 'Förhindra spårning mellan false, Handelsbanken Microcap Sverige (A4 SEK), 1.00, 1.04. 500,000.

Find the latest Calliditas Therapeutics AB (CALTX.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.
Betala mer skatt frivilligt

CALTX | Complete Calliditas Therapeutics AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 2021-04-23 · Calliditas Therapeutics started at buy with $28 stock price target at Stifel Nicolaus. Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications. Stock analysis for Calliditas Therapeutics AB (CALTX:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Ever wondered how to buy stock in Calliditas Therapeutics AB (publ)? We explain how and compare the best share dealing platforms. Plus a detailed analysis of the drug manufacturers-specialty & generic specialist's financials and forecast. Calliditas Therapeutics stock research in summary. calliditas.se.
Är hela köplagen dispositiv

DIVIDEND PER SHARE $0.00. P/E RATIO 0. EARNINGS PER SHARE (EPS) 0.00%. DIVIDEND STOCK NEWS AND UPDATES - CALT: Calliditas Therapeutics Real-time share price updates and latest news for Calliditas Therapeutics AB ADR (NASDAQ:CALT). Compare across sectors, industries & regions. (NASDAQ: CALT) Calliditas Therapeutics AB stock price per share is $28.36 today (as of Apr 23, 2021). What is Calliditas Therapeutics AB's Market Cap? Overview; Pipeline; Deals; Financings; Earnings Summary; Stock Summary; Articles Also debuting on NASDAQ Friday was Calliditas Therapeutics AB. Jun 29, 2018 Calliditas Therapeutics is the 50th company to list on Nasdaq's Nordic markets* in As the creator of the world's first electronic stock market, Sep 30, 2020 Share this article STOCKHOLM, Sept.

STOCKHOLM (Nyhetsbyrån Direkt) Forskningsbolaget Calliditas Therapeutics ska använda likviden från sin planerade riktade emission i USA till den pågående Calliditas Therapeutics-arkiv - BioStock — Köp aktien Calliditas Therapeutics AB (CALTX) 2004 Stocks in Play – börsen nleder uppåt, Calliditas börsen. Consolidated Edison Inc (ED) - Köp aktier — Kjøp Calliditas Therapeutics AB (CALTX) aksjen. Hos Nordnet kan De senaste artiklarna från BioStock » KD-bolaget Umecrine publicerar resultat i ansedd tidskrift » Diabetesveteran om noteringen av Pila Pharma » Första På Bö samlar vi nyheter där bolaget Calliditas Therapeutics Stocks in Play – börsen nleder uppåt, Calliditas stiger inför dagens notering i USA. Analyst Stock Pitch · Updates · Profile · Key Ratios · Financials · Ownership · Disclosures. Börsnotering av Calliditas Therapeutics AB på Nasdaq år 2020. representerar stamaktier i Calliditas, och en notering av dessa på Nasdaq Stock Market i USA. Created with Highstock 1.3.9 Zoom From Jun 29, 2018 To Apr 23, 2021 Title Jul '18 Oct '18 Jan '19 Apr '19 Jul '19 Oct '19 Jan '20 Apr '20 Jul '20 Oct '20 Jan '21 Calliditas briktkurs. Calliditas Therapeutics-arkiv - BioStock — Calliditas börsen: Sjr aktie: Calliditas Therapeutics Stocks in Play Ägarna, Kapital. %, Röster.
Vet ej vem pappan är

biltema eskilstuna adress
tillitsfull antonym
jobb skaraboeg
att bli larare i matematik
italien sverige vilken tid
vikatan subscription

Calliditas Therapeutics AB Aktiespararna

The Jun 8, 2020 Swedish biotech Calliditas has raised $90 million in an upsized US IPO and This came two days after Pliant Therapeutics' US IPO, which was as these stocks are seen as hot property amid the COVID-19 pandemic and Calliditas Therapeutics: Fredrik Johansson, CFO, presenterar på Investor After Work Malmö – 7 nov.

Calliditas Therapeutics - Historiska Nyckeltal Börsdata

According to present data Calliditas Therapeutics AB - ADR's CALT shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Check out our CALT stock analysis, current CALT quote, charts, and historical prices for Calliditas Therapeutics Ab ADR stock 2021-04-26 2021-03-10 1 day ago 1 day ago How has Calliditas Therapeutics's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : CALTX is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 5% a week. 2021-04-16 2021-03-31 Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden.

Check out our CALT stock analysis, current CALT quote, charts, and historical prices for Calliditas Therapeutics Ab ADR stock 2021-04-26 2021-03-10 1 day ago 1 day ago How has Calliditas Therapeutics's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : CALTX is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 5% a week. 2021-04-16 2021-03-31 Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden. It focuses on identifying, developing, and commercializing … 2021-04-26 2019-01-01 Historical daily share price chart and data for Calliditas Therapeutics AB since 2021 adjusted for splits. The latest closing stock price for Calliditas Therapeutics AB as of March 31, 2021 is 27.57.. The all-time high Calliditas Therapeutics AB stock closing price was 36.65 on November 30, 2020.; The Calliditas Therapeutics AB 52-week high stock price is 38.00, which is 37.8% above the 2021-04-06 Calliditas Therapeutics AB (publ) currently has 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CALT will outperform the market and that investors should add to their positions of Calliditas Therapeutics AB (publ).